IBB News and Press, iShares Biotechnology ETF From 09/12/25

2025-09-12 11:30:00 ET Pharma and biotech stocks have struggled lately as uncertainty over the potential impact of tariffs and pricing pressures. Jasper Hellweg, Security Analyst with Argus Research, joins MoneyTalk to discuss how new treatment types and U.S. policy changes could be cat...

2025-09-12 02:10:00 ET By Carrie King ... Read the full article on Seeking Alpha For further details see: Earnings Offer Evidence That U.S. Stocks Can Keep On Keepin' On

2025-09-12 01:10:00 ET By Shea Wihlborg Introduction Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. 1 While statins can reduce the risk of heart attacks by ~29%, 2 r...

2025-09-05 13:40:00 ET September has historically been a tough month for stocks. But things could be different this time around. David Sekera, Chief U.S. Market Strategist with Morningstar Research, says the markets have entered the month trading at fair value. He discusses potential op...

2025-09-05 03:30:00 ET By Frank Coughlin In the second quarter, several overarching themes emerged from earnings calls, painting a picture of a business landscape in flux. Tariffs and policy uncertainty, which were dominant themes in Q1, continue to weigh on corporate strategy.....

2025-09-01 08:03:56 ET The biotechnology industry, known to be in the fast growing sectors of healthcare, is gaining momentum due to innovations like AI, which can support drug research of CRISPR gene editing. For investors building positions in healthcare, investing in biotech companie...

2025-08-28 16:10:00 ET The Healthcare sector has struggled this year, driven partly by volatile U.S. tariff, research and funding policies. Jacky He, Vice President, Portfolio Research, TD Asset Management, joins MoneyTalk to discuss how investor sentiment could be changing as the secto...

2025-08-16 03:20:00 ET 5 Key Macro Trends 1. Trade optimism is boosting risk appetite. Progress in trade discussions between the U.S. and key trading partners has helped spark a rally in mega-cap and speculative small-cap stocks. Simultaneously, rising market confidence ...

2025-08-15 09:35:23 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Life Expectancy, Patents, And A Positive Outlook Will Pave The Way XLV: The S&P 500's Most Discounted Sector? Uncover The Hidden Risk Understanding XLV: A Sector ETF Focused On ...

2025-08-14 03:10:00 ET Risk aversion returned for US equity investors in August. After briefly regaining risk appetite in July, S&P Global Market Intelligence's latest Investment Manager Index survey showed a return to risk avoidance with a negative 20% reading. The index measur...